Superstring Capital Management as of March 31, 2025
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 34 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zai Lab Adr (ZLAB) | 12.7 | $11M | 295k | 36.14 | |
| Bridgebio Pharma (BBIO) | 7.6 | $6.4M | 184k | 34.57 | |
| Verona Pharma Sponsored Ads (VRNA) | 7.3 | $6.1M | 97k | 63.49 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 6.5 | $5.4M | 160k | 33.93 | |
| Pfizer (PFE) | 5.9 | $5.0M | 196k | 25.34 | |
| Urogen Pharma (URGN) | 5.6 | $4.7M | 424k | 11.06 | |
| Cogent Biosciences (COGT) | 5.5 | $4.6M | 775k | 5.99 | |
| Oric Pharmaceuticals (ORIC) | 5.4 | $4.6M | 819k | 5.58 | |
| Travere Therapeutics (TVTX) | 5.1 | $4.3M | 238k | 17.92 | |
| Terns Pharmaceuticals (TERN) | 4.5 | $3.7M | 1.4M | 2.76 | |
| Cytokinetics Com New (CYTK) | 3.5 | $2.9M | 73k | 40.19 | |
| Savara (SVRA) | 3.2 | $2.7M | 966k | 2.77 | |
| Summit Therapeutics (SMMT) | 3.0 | $2.5M | 132k | 19.29 | |
| Springworks Therapeutics (SWTX) | 2.8 | $2.4M | 54k | 44.13 | |
| Capricor Therapeutics Com New (CAPR) | 2.7 | $2.3M | 241k | 9.49 | |
| Verastem Com New (VSTM) | 2.4 | $2.0M | 336k | 6.03 | |
| Protara Therapeutics Com Stk (TARA) | 1.8 | $1.5M | 360k | 4.26 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $1.5M | 44k | 33.54 | |
| Soleno Therapeutics (SLNO) | 1.6 | $1.4M | 19k | 71.45 | |
| Madrigal Pharmaceuticals (MDGL) | 1.5 | $1.3M | 3.8k | 331.23 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.5 | $1.3M | 32k | 39.07 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.2 | $1.1M | 756k | 1.39 | |
| Tectonic Therapeutic (TECX) | 1.1 | $899k | 51k | 17.71 | |
| Zenas Biopharma (ZBIO) | 1.0 | $882k | 112k | 7.90 | |
| 89bio (ETNB) | 0.9 | $794k | 109k | 7.27 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $657k | 22k | 29.52 | |
| Cabaletta Bio (CABA) | 0.8 | $636k | 459k | 1.39 | |
| Vaxcyte (PCVX) | 0.5 | $425k | 11k | 37.76 | |
| Kyverna Therapeutics (KYTX) | 0.4 | $369k | 191k | 1.93 | |
| Ocular Therapeutix (OCUL) | 0.4 | $310k | 42k | 7.33 | |
| Schrodinger (SDGR) | 0.3 | $279k | 14k | 19.74 | |
| Century Therapeutics (IPSC) | 0.3 | $220k | 463k | 0.48 | |
| Cumberland Pharmaceuticals Call Option (CPIX) | 0.3 | $212k | 50k | 4.23 | |
| Lakeshore Biopharma Ord Shs New (LSBCF) | 0.1 | $75k | 31k | 2.42 |
